Skip to main content

Atea Pharmaceuticals, Inc.

AVIR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001593899

No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Atea Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of AVIR: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders108113+5
Shares55.1M54.4M−728.1K (−1.3%)
Value$168.3M$219.6M+$51.3M (+30.5%)

New holders (19)

Institutions that held Atea Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to AVIR in Q1 2024
InstitutionSharesValue% of portfolio
Wellington Management Group LLP350,004$1.41M0.00%
LPL Financial LLC34,000$137.4K0.00%
Mirae Asset Global Investments Co., Ltd.30,465$97.3K0.00%
Numerai GP LLC22,580$91.2K0.04%
Toroso Investments, LLC21,472$86.7K0.00%
Squarepoint Ops LLC20,153$81.4K0.00%
Group One Trading, L.P.16,828$68.0K0.00%
Belvedere Trading LLC10,519$42.5K0.00%
Gladius Capital Management LP8,540$34.5K0.03%
Point72 (DIFC) Ltd6,230$25.2K0.00%
Point72 Asia (Singapore) Pte. Ltd.5,500$22.2K0.01%
Clear Street Markets LLC3,400$14.0K0.01%
US Bancorp2,900$11.7K0.00%
Capital Advisors, Ltd. LLC1,641$7.00K0.00%
Quadrant Capital Group LLC319$1.29K0.00%
Signaturefd, LLC99$4000.00%
Northwestern Mutual Wealth Management Co75$3030.00%
Federation des caisses Desjardins du Quebec24$970.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC15$600.00%

Sold out (14)

Institutions that held Atea Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.